← Back to directory

Michael S. Pepper

Researcher Next ID · RN-030626

Researcher · Biochemistry, Genetics and Molecular Biology

University of Pretoria

Pretoria, South Africa

Not currently recruitingFunding unknown
Works count
492
Citation count
27,252
H-index
86
i10-index
259

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Angiogenesis and VEGF in Cancer
Mesenchymal stem cell research
Biomedical Ethics and Regulation
Lymphatic System and Diseases
Protease and Inhibitor Mechanisms

Publications

  • SARS-CoV-2 Variants, Vaccines, and Host Immunity

    Frontiers in Immunology · 2022 · 10.3389/fimmu.2021.809244

  • Adipogenesis: A Complex Interplay of Multiple Molecular Determinants and Pathways

    International Journal of Molecular Sciences · 2020 · 10.3390/ijms21124283

  • The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer

    International Journal of Molecular Sciences · 2017 · 10.3390/ijms18071586

  • The Role of Reactive Oxygen Species in Mesenchymal Stem Cell Adipogenic and Osteogenic Differentiation: A Review

    Stem Cells and Development · 2015 · 10.1089/scd.2014.0484

  • Adipocyte and adipogenesis

    European Journal of Cell Biology · 2013 · 10.1016/j.ejcb.2013.06.001

  • Molecular characterization of lymphatic endothelial cells

    Proceedings of the National Academy of Sciences · 2002 · 10.1073/pnas.242401399

  • Lymphangiogenesis and tumor metastasis: myth or reality?

    PubMed · 2001

  • Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis

    Arteriosclerosis Thrombosis and Vascular Biology · 2001 · https://doi.org/10.1161/hq0701.093685

  • Regulation of Angiopoietin-2 mRNA Levels in Bovine Microvascular Endothelial Cells by Cytokines and Hypoxia

    Circulation Research · 1998 · 10.1161/01.res.83.8.852

  • Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

    Proceedings of the National Academy of Sciences · 1998 · 10.1073/pnas.95.20.11709

  • Expression of vascular endothelial growth factor in digestive neuroendocrine tumours

    Histopathology · 1998 · 10.1046/j.1365-2559.1998.00321.x

  • Manipulating Angiogenesis

    Arteriosclerosis Thrombosis and Vascular Biology · 1997 · 10.1161/01.atv.17.4.605

  • Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity

    Cytokine & Growth Factor Reviews · 1997 · https://doi.org/10.1016/s1359-6101(96)00048-2

  • Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.

    PubMed · 1997

  • Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.

    PubMed · 1995 · 10.1093/jn/125.suppl_3.790s

  • Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells

    Journal of Biological Chemistry · 1995 · 10.1074/jbc.270.17.9709

  • The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

    Nature · 1994 · https://doi.org/10.1038/368237a0

  • Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

    Proceedings of the National Academy of Sciences · 1993 · https://doi.org/10.1073/pnas.90.7.2690

  • Biphasic Effect of Transforming Growth Factor-β1 on in Vitro Angiogenesis

    Experimental Cell Research · 1993 · 10.1006/excr.1993.1043

  • Upregulation of urokinase receptor expression on migrating endothelial cells

    The Journal of Cell Biology · 1993 · 10.1083/jcb.122.3.673

  • Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

    Biochemical and Biophysical Research Communications · 1992 · https://doi.org/10.1016/0006-291x(92)92277-5

  • Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

    Biochemical and Biophysical Research Communications · 1991 · 10.1016/0006-291x(91)91276-i

  • Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene

    Cell · 1990 · 10.1016/0092-8674(90)90009-4

  • Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.

    The Journal of Cell Biology · 1990 · 10.1083/jcb.111.2.743

  • Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.

    The Journal of Cell Biology · 1987 · 10.1083/jcb.105.6.2535

Current projects

    No projects listed.